DE60137534D1 - Calciumkanalantagonisten vom n-typ zur behandlung von schmerzen - Google Patents
Calciumkanalantagonisten vom n-typ zur behandlung von schmerzenInfo
- Publication number
- DE60137534D1 DE60137534D1 DE60137534T DE60137534T DE60137534D1 DE 60137534 D1 DE60137534 D1 DE 60137534D1 DE 60137534 T DE60137534 T DE 60137534T DE 60137534 T DE60137534 T DE 60137534T DE 60137534 D1 DE60137534 D1 DE 60137534D1
- Authority
- DE
- Germany
- Prior art keywords
- pain
- treatment
- type
- calcium channel
- channel antagonists
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/38—Nitrogen atoms
- C07D215/42—Nitrogen atoms attached in position 4
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pain & Pain Management (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Quinoline Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE0004056A SE0004056D0 (sv) | 2000-11-06 | 2000-11-06 | N-type calcium channel antagonists for the treatment of pain |
| PCT/SE2001/002391 WO2002036569A1 (en) | 2000-11-06 | 2001-10-31 | N-type calcium channel antagonists for the treatment of pain |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE60137534D1 true DE60137534D1 (de) | 2009-03-12 |
Family
ID=20281716
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE60137534T Expired - Fee Related DE60137534D1 (de) | 2000-11-06 | 2001-10-31 | Calciumkanalantagonisten vom n-typ zur behandlung von schmerzen |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US6841680B2 (de) |
| EP (1) | EP1339690B1 (de) |
| JP (1) | JP2004513118A (de) |
| AT (1) | ATE421502T1 (de) |
| AU (1) | AU2002212897A1 (de) |
| DE (1) | DE60137534D1 (de) |
| ES (1) | ES2319259T3 (de) |
| SE (1) | SE0004056D0 (de) |
| WO (1) | WO2002036569A1 (de) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2862301B1 (fr) * | 2003-11-17 | 2007-12-21 | Aventis Pharma Sa | Nouveau procede de preparation de quinoleines 3-fluorees |
| US20080300262A1 (en) * | 2005-04-08 | 2008-12-04 | Snutch Terrance P | Combination Therapy for Relief of Pain |
| EP2019676A2 (de) * | 2006-05-11 | 2009-02-04 | Neuromed Pharmaceuticals, Ltd. | Verfahren zur erhöhung der bioverfügbarkeit von benzhydrylpiperazinhaltigen verbindungen |
| BR112013010333A2 (pt) * | 2010-10-29 | 2017-07-25 | Clino Ltd | sonda de imageamento de tau |
| MX2013010306A (es) | 2011-03-08 | 2013-12-09 | Zalicus Pharmaceuticals Ltd | Formulaciones de dispersion solida y metodos de uso de las mismas. |
| US8409560B2 (en) | 2011-03-08 | 2013-04-02 | Zalicus Pharmaceuticals Ltd. | Solid dispersion formulations and methods of use thereof |
| DE102016125645A1 (de) * | 2016-12-23 | 2018-06-28 | Forschungszentrum Jülich GmbH | D-enantiomere Peptide zur Therapie von chronischem und neuropathischem Schmerz |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5506235A (en) * | 1991-08-02 | 1996-04-09 | Pfizer Inc. | Quinoline derivatives as immunostimulants |
-
2000
- 2000-11-06 SE SE0004056A patent/SE0004056D0/xx unknown
-
2001
- 2001-10-31 WO PCT/SE2001/002391 patent/WO2002036569A1/en active Application Filing
- 2001-10-31 US US10/415,783 patent/US6841680B2/en not_active Expired - Fee Related
- 2001-10-31 EP EP01981242A patent/EP1339690B1/de not_active Expired - Lifetime
- 2001-10-31 AU AU2002212897A patent/AU2002212897A1/en not_active Abandoned
- 2001-10-31 AT AT01981242T patent/ATE421502T1/de not_active IP Right Cessation
- 2001-10-31 DE DE60137534T patent/DE60137534D1/de not_active Expired - Fee Related
- 2001-10-31 ES ES01981242T patent/ES2319259T3/es not_active Expired - Lifetime
- 2001-10-31 JP JP2002539329A patent/JP2004513118A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| US20040053965A1 (en) | 2004-03-18 |
| EP1339690A1 (de) | 2003-09-03 |
| SE0004056D0 (sv) | 2000-11-06 |
| AU2002212897A1 (en) | 2002-05-15 |
| JP2004513118A (ja) | 2004-04-30 |
| ES2319259T3 (es) | 2009-05-06 |
| EP1339690B1 (de) | 2009-01-21 |
| ATE421502T1 (de) | 2009-02-15 |
| US6841680B2 (en) | 2005-01-11 |
| WO2002036569A1 (en) | 2002-05-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60118956D1 (de) | Calciumkanalantagonisten vom n-typ zur behandlung von schmerzen | |
| DE60113496D1 (de) | Verwendung von Glycyrrhizin zur Behandlung von Mastitis. | |
| ATE407676T1 (de) | Topoisomerasehemmern zur behandlung von chirurgischen verklebungen | |
| DE60117977D1 (de) | Vorrichtungen zur behandlung von harninkontinenz | |
| ATE250576T1 (de) | Substituierte pyrrolylverbindungen zur behandlung von entzündungen | |
| ATE305788T1 (de) | (s,s)-reboxetin zur behandlung von inkontinenz | |
| DE69941586D1 (de) | Verwendung von Uridin in Kombination mit Cholin zur Behandlung von Gedächtnisstörungen | |
| SE9900100D0 (sv) | New compounds | |
| CY1107054T1 (el) | Ενωσεις διτοσυλικου αλατος κιναζολινης | |
| ATE410430T1 (de) | 2,3-dihydro-6-nitroimidazoä2,1- büoxazolverbindungen zur behandlung von tuberkulose | |
| HUP0301948A2 (hu) | Guanidin-sókon alapuló biocid polimerek | |
| DE60101354T2 (de) | Diorganopolysiloxan/Acrylat-Copolymer enthaltende Emulsionen zur Behandlung von Flächengebilden | |
| ATE255894T1 (de) | Mglur5 antagonisten zur behandlung von schmerzen und angstzuständen | |
| DE60216495D1 (de) | Vaginale zusammensetzung enthaltend lidocaine zur behandlung von gebärmutterrhythmusstörung | |
| DE60136397D1 (de) | Konjugiertes Dienkautschukgel, Kautschukzusammensetzungen die dieses enthalten und Verfahren zur Herstellung von konjugiertem Dienkautschuk | |
| DE60136477D1 (de) | Retinoide zur behandlung von emphysem | |
| CY1108599T1 (el) | Η απλιδινη στην αντιμετωπιση του πολλαπλου μυελωματος | |
| DE60204232D1 (de) | Antagonisten für calciumkanäle vom n-typ zur behandlung von schmerzen | |
| SE0004054D0 (sv) | N-type calcium channel antagonists for the treatment of pain | |
| DE60132072D1 (de) | Verwendungen zur behandlung von fsh-verbundenen zuständen mit gnrh antagonisten | |
| ATE421502T1 (de) | Calciumkanalantagonisten vom n-typ zur behandlung von schmerzen | |
| DE69727711D1 (de) | N-alkyl-ammonium-acetonitril-salze, methoden dazu und zusammensetzungen die diese enthalten | |
| DE60139195D1 (de) | Aktivierbare polymerzusammensetzung, und gegenstände, die diese nutzen | |
| DK1100824T3 (da) | Forbindelser med væksthormonfrigivende egenskaber | |
| SE0004055D0 (sv) | N-type calcium channel antagonists for the treatment of pain |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8364 | No opposition during term of opposition | ||
| 8339 | Ceased/non-payment of the annual fee |